Brief: Orchard Therapeutics Posts Quarterly Loss Per Share 48 Cents
06/08/2020 13:04
Aug 6 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS ADVANCES NEW STRATEGIC PLAN AND
REPORTS
SECOND QUARTER 2020 FINANCIAL RESULTS
* ORCHARD THERAPEUTICS PLC - NEAR-TERM FINANCIAL POSITION
SECURE
WITH CASH AND INVESTMENTS OF ABOUT $230 MILLION AND RUNWAY INTO
2022
* ORCHARD THERAPEUTICS PLC QTRLY LOSS PER SHARE 48 CENTS
Source text for Eikon: ID:nGNX8qNbKQ
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln